$2.42
0.01000.41%
At close: -
$2.48
0.062.48%
After Hours: 7:59 PM EDT
Comments
Loading...
Lipella Pharmaceuticals (LIPO) Forecast
NewsEarningsLipella Pharmaceuticals (LIPO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestLipella Pharmaceuticals (NASDAQ:LIPO) Stock Quotes, Forecast and News Summary
Lipella Pharmaceuticals Stock (NASDAQ: LIPO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Lipella Pharmaceuticals (LIPO) stock?
You can purchase shares of Lipella Pharmaceuticals (NASDAQ:LIPO) through any online brokerage.
Who are Lipella Pharmaceuticals (LIPO) competitors?
Other companies in Lipella Pharmaceuticals’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC), NuCana (NASDAQ:NCNA) and Alaunos Therapeutics (NASDAQ:TCRT).
What is the forecast, or price target, for Lipella Pharmaceuticals (LIPO) stock?
Lipella Pharmaceuticals has a consensus price target of $2.00.
What is the current price for Lipella Pharmaceuticals (LIPO)?
The stock price for Lipella Pharmaceuticals (NASDAQ: LIPO) is $2.48 last updated November 21, 2024 at 7:59 PM EST.
Does Lipella Pharmaceuticals (LIPO) pay a dividend?
There are no upcoming dividends for Lipella Pharmaceuticals.
When is Lipella Pharmaceuticals (NASDAQ:LIPO) reporting earnings?
Lipella Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is Lipella Pharmaceuticals (LIPO) going to split?
There is no upcoming split for Lipella Pharmaceuticals.
What sector and industry does Lipella Pharmaceuticals (LIPO) operate in?
Lipella Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.